CollPlant Biotechnologies New
Open
$0.42
Prev. Close
$0.42
High
$0.42
Low
$0.33
Market Snapshot
$4.34M
-0.3
-1.46
$515K
39
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 39 full-time employees. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 39 full-time employees. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Recently from Cashu
CollPlant Biotechnologies Faces Nasdaq Compliance Challenge Over Share Price Requirements
CollPlant Biotechnologies Faces Nasdaq Compliance Challenge CollPlant Biotechnologies, a prominent player in the regenerative and aesthetic medicine sector, currently navigates a critical compliance c…
CollPlant Biotechnologies: Innovating Regenerative Medicine with Plant-Derived Collagen Solutions
CollPlant Biotechnologies: Pioneering Developments in Regenerative Medicine CollPlant Biotechnologies is at the forefront of innovation in the field of regenerative medicine, focusing on the developme…
CollPlant Biotechnologies Set for Key Earnings Announcement on November 26, 2025
CollPlant Biotechnologies Prepares for Critical Earnings Announcement CollPlant Biotechnologies is on the cusp of announcing its quarterly earnings on November 26, 2025, a milestone that holds signifi…
CollPlant Biotechnologies Gears Up for Earnings Release Amid Strategic Growth Initiatives
CollPlant Biotechnologies Prepares for Earnings Release Amid Strategic Growth Focus As CollPlant Biotechnologies approaches its quarterly earnings announcement scheduled for November 26, 2025, the reg…